Targeting of HDAC8 and investigational inhibitors in neuroblastoma
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728220903241658
Reference103 articles.
1. Neuroblastoma: biological insights into a clinical enigma
2. Genetic parameters of neuroblastomas
3. Epigenetic therapy of cancer: past, present and future
4. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
5. HDACi – Targets beyond chromatin
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting cancers and metabolic disorders: The prospects of combining HDAC8 inhibitor and activator;European Journal of Medicinal Chemistry Reports;2023-04
2. HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma;Cancers;2023-02-09
3. Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study;European Journal of Medicinal Chemistry;2022-12
4. Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening;Journal of Biomolecular Structure and Dynamics;2022-11-12
5. A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors;International Journal of Molecular Sciences;2022-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3